Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Vulcan Consulting Limited naming David Cullinane .
Filed returns
39
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Vulcan Consulting Limited | Economic Development and Industry | National Life Sciences Strategy (Public policy or programme) | 16 | On lobbying.ie |
| May–Aug 2026 | Vulcan Consulting Limited | Health | Diabetes Policy in Ireland (Public policy or programme) | 10 | On lobbying.ie |
| May–Aug 2026 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2026 | Vulcan Consulting Limited | Health | Organising an event to launch a Cancer Dashboard for Ireland (Public policy or programme) | 45 | On lobbying.ie |
| Jan–Apr 2026 | Vulcan Consulting Limited | Health | Diabetes Policy in Ireland (Public policy or programme) | 35 | On lobbying.ie |
| Jan–Apr 2026 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2025 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 17 | On lobbying.ie |
| May–Aug 2025 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 26 | On lobbying.ie |
| Jan–Apr 2025 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2025 | Vulcan Consulting Limited | Health | Rare Disease Policy (Public policy or programme) | 23 | On lobbying.ie |
| Sep–Dec 2024 | Vulcan Consulting Limited | Health | Strategic Operations in Ireland & Healthcare Priorities (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2024 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 92 | On lobbying.ie |
| Sep–Dec 2024 | Vulcan Consulting Limited | Health | Rare Disease Policy (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2024 | Vulcan Consulting Limited | Health | Rare Disease Policy (Public policy or programme) | 12 | On lobbying.ie |
| May–Aug 2024 | Vulcan Consulting Limited | Health | Strategic Operations in Ireland & Healthcare Priorities (Public policy or programme) | 40 | On lobbying.ie |
| May–Aug 2024 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 27 | On lobbying.ie |
| Jan–Apr 2024 | Vulcan Consulting Limited | Health | Diabetes Policy in Ireland (Public policy or programme) | 19 | On lobbying.ie |
| Jan–Apr 2024 | Vulcan Consulting Limited | Health | Rare Disease Policy (Public policy or programme) | 21 | On lobbying.ie |
| Jan–Apr 2024 | Vulcan Consulting Limited | Health | EU Pharmaceutical Strategy (Legislation) | 38 | On lobbying.ie |
| Jan–Apr 2024 | Vulcan Consulting Limited | Health | Strategic Operations in Ireland & Medicines Policy (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2024 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 28 | On lobbying.ie |
| Sep–Dec 2023 | Vulcan Consulting Limited | Health | Diabetes Policy in Ireland (Public policy or programme) | 12 | On lobbying.ie |
| Sep–Dec 2023 | Vulcan Consulting Limited | Health | Rare Disease Policy (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2023 | Vulcan Consulting Limited | Health | EU Pharmaceutical Strategy (Legislation) | 5 | On lobbying.ie |
| Sep–Dec 2023 | Vulcan Consulting Limited | Health | Strategic Operations in Ireland & Medicines Policy (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2023 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 21 | On lobbying.ie |
| May–Aug 2023 | Vulcan Consulting Limited | Health | Diabetes Policy in Ireland (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2023 | Vulcan Consulting Limited | Health | Rare Disease Policy (Public policy or programme) | 60 | On lobbying.ie |
| May–Aug 2023 | Vulcan Consulting Limited | Health | EU Pharmaceutical Strategy (Legislation) | 6 | On lobbying.ie |
| May–Aug 2023 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 25 | On lobbying.ie |
| Jan–Apr 2023 | Vulcan Consulting Limited | Health | EU Pharmaceutical Strategy (Public policy or programme) | 12 | On lobbying.ie |
| Sep–Dec 2022 | Vulcan Consulting Limited | Health | EU Pharmaceutical Strategy (Public policy or programme) | 21 | On lobbying.ie |
| Sep–Dec 2022 | Vulcan Consulting Limited | Agriculture | Forestry policy and programmes (Public policy or programme) | 12 | On lobbying.ie |
| Sep–Dec 2022 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 21 | On lobbying.ie |
| May–Aug 2022 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 23 | On lobbying.ie |
| Sep–Dec 2021 | Vulcan Consulting Limited | Environment | Seeking policy adoption towards air filtration and ventilation as part of Government's COVID-19 strategy (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2021 | Vulcan Consulting Limited | Environment | Seeking policy adoption towards air filtration and ventilation as part of Government's COVID-19 strategy (Public policy or programme) | 18 | On lobbying.ie |
| Sep–Dec 2019 | Vulcan Consulting Limited | Agriculture | Forestry Policy and Programmes (Public policy or programme) | 15 | On lobbying.ie |
| Sep–Dec 2019 | Vulcan Consulting Limited | Sports and Recreation | Secondary Ticketing Legislation (Public policy or programme) | 8 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 33 | 84.6% | |
| Agriculture | 2 | 5.1% | |
| Environment | 2 | 5.1% | |
| Economic Development and Industry | 1 | 2.6% | |
| Sports and Recreation | 1 | 2.6% |